UBS O'Connor’s Surrozen SRZN Stock Holding History

UBS O'Connor’s Portfolio SRZN Stock Details SRZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,517	Closed	-$822K	–	985
2021 Q2	$822K	Sell	5,517 -4,476	-45%	-$663K	0.01%	578
2021 Q1	$1.44M	Buy	+9,993	New	+$1.52M	0.02%	521

Other funds holding SRZN

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Trustees of Columbia University in the City of New York New York $891M AUM 17.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

UBS O'Connor's SRZN Position: Q3 2021 in Review

UBS O'Connor sold out of Surrozen (SRZN) in Q3 2021, closing a stake of 5,517 shares — an estimated $822K sold.

UBS O'Connor first reported a position in SRZN in Q1 2021 and held it in 2 quarters. The position peaked at $1.44M in Q1 2021. 28 funds tracked by Wall St. Rank hold SRZN as of Q3 2021.

UBS O'Connor reported no remaining Surrozen position as of Q3 2021 after selling out during the quarter.
UBS O'Connor sold 5,517 Surrozen shares in Q3 2021, an estimated $822K.
UBS O'Connor first reported a position in Surrozen in Q1 2021 and held it in 2 quarters.
UBS O'Connor's Surrozen position peaked at $1.44M in Q1 2021.
28 funds tracked by Wall St. Rank held Surrozen as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.